Keyphrases
Kidney Transplant Evaluation
66%
Confidence Interval
48%
Odds Ratio
44%
Liver Transplantation
44%
Risk Factors
38%
Graft Survival
37%
Kidney Transplant
26%
Abnormal Cervical Cytology
22%
Outcome Differences
22%
Survival Prediction
22%
SLC24A5
22%
United States
22%
Antithymocyte Globulin
22%
Young children
22%
Orchialgia
22%
Pigmentation
22%
Kidney Transplantation
22%
Young Adolescents
22%
Zebrafish
22%
High Acuity
22%
Simultaneous Pancreas-kidney Transplant
22%
Colonoscopy
22%
Underreported
22%
Screening Colonoscopy
22%
Testicular Pain
22%
Chronic Kidney Disease Patients
22%
Mammography
22%
Donor Nephrectomy
22%
Cation Exchanger
22%
Health-related Quality of Life
22%
Short Form 36 (SF-36)
22%
Induction Agents
22%
Living Liver Donor
22%
Liver Transplant Recipients
22%
Occult
22%
Lessons Learned
22%
Alcohol Use
22%
Quality Improvement Initiatives
22%
Pancreas Transplantation
22%
Single-center Experience
22%
Post-transplant Lymphoproliferative Disorder
22%
Dialysis
19%
Transplant Evaluation
16%
Renal Failure
16%
Adenomatous Polyps
16%
Transplant Center
16%
MELD Score
14%
1-year Survival
14%
Melanosome
14%
Simultaneous Pancreas-kidney
14%
Medicine and Dentistry
Kidney Graft
100%
Transplantation
61%
Graft Survival
40%
Liver Graft
37%
Chronic Kidney Disease
33%
Odds Ratio
33%
Pancreas Transplantation
29%
Living Donors
27%
Liver Transplantation
22%
Uterine Cervix Cytology
22%
Alcohol Consumption
22%
Kidney Transplantation
22%
Colonoscopy
22%
Nephrectomy
22%
Quality Improvement
22%
Testicular Pain
22%
Mammography
22%
Thymocyte Antibody
22%
Anesthesia Induction
22%
Kidney Pancreas Transplantation
22%
Toddlers
22%
Quality of Life
22%
Short Form 36
22%
Posttransplant Lymphoproliferative Disease
22%
Adolescence
22%
Cancer
15%
Acute Graft Rejection
13%
Patient History of Kidney Transplantation
13%
Biopsy Technique
12%
Graft Failure
12%
Logistic Regression Analysis
11%
Renal Failure
11%
Interleukin 2 Receptor
11%
Receptor Antagonist
11%
Population
11%
Alemtuzumab
11%
Liver Disease
9%
Cervical Cancer Screening
8%
Cytotechnology
8%
Tubular Adenoma
8%
Ischemia
7%
Scrotal Swelling
7%
Breast Density
6%
Immunosuppressive Treatment
6%
Health Outcomes
5%
Hepatectomy
5%